Filing Flows › Comparisons › CCEL vs MGRX
Cryo Cell International vs Mangoceuticals: CCEL and MGRX compared
Cryo Cell International is the larger company: $7.8M of revenue in its latest quarter (Q3 FY26) against $69K for Mangoceuticals (Q2 2026). Cryo Cell International is growing faster (0% against -59% a year earlier).
Where the money goes: CCEL and MGRX
Cryo Cell International (CCEL) · Q3 FY26
Cryo Cell International, Q3 FY26: revenue $7.8M (0% year over year), operating margin 28.0%, net earnings $1.3M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Mangoceuticals (MGRX) · Q2 2026
Mangoceuticals, Q2 2026: revenue $69K (-59% year over year), net loss $1.3M, operating cash flow −$261K. The chart follows the revenue to costs, profit and cash.
| Cryo Cell International (CCEL) | Mangoceuticals (MGRX) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q2 2026 |
| Revenue | $7.8M | $69K |
| Revenue growth, Y/Y | 0% | -59% |
| Operating margin | 28.0% | n/m |
| Net earnings | $1.3M | −$1.3M |
| Net margin | 16.2% | — |
| Operating cash flow | $1.1M | −$261K |
| Free cash flow | $1.0M | — |
Where the revenue comes from
Cryo Cell International
- Processing and Storage Fees: $7.7M (98%)
- Public Banking: $135K (2%)
- Product: $39K (0%)
Questions
Which is bigger, Cryo Cell International or Mangoceuticals?
Cryo Cell International is the larger company: $7.8M of revenue in its latest quarter (Q3 FY26) against $69K for Mangoceuticals (Q2 2026).
Is Cryo Cell International or Mangoceuticals growing faster?
Cryo Cell International is growing faster (0% against -59% a year earlier).
More: Cryo Cell International earnings · how Cryo Cell International makes money · Mangoceuticals earnings · how Mangoceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 9, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.